Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Abliva completes phase Ia/Ib study with KL1333

This week, Lund-based Abliva announced the completion of the phase Ia/Ib study with the company’s lead candidate KL1333. The study was designed to evaluate the safety and pharmacokinetics for KL1333, which is an important step before the upcoming phase II/III efficacy study that is expected to begin later this year. BioStock has spoken with Abliva’s chief medical officer Magnus Hansson to find out more.Read the full article at biostock.se: https://www.biostock.se/en/abliva-completes-phase-ia-ib-study-with-kl1333/This is a press release from BioStock - Connecting Innovation & Capital.

Change in the Board of Directors at DanCann Pharma A/S

COPENHAGEN, Denmark, 19 March 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby announce that Magnus Østergaard Dahlmann has chosen to transfer the position of Chairman of the Board of Directors of the biopharmaceutical company DanCann Pharma A/S to Carsten Trads due to health reasons. Magnus Østergaard Dahlmann will continue as a member of the company’s Board of Directors.The change of chairmanship is quite undramatic and is due to a desire from Magnus Østergaard Dahlmann to disengage resources in connection with a long-term course of treatment, and

Change in the holding of Kesko Corporation's treasury shares

Kesko Corporation has today transferred a total of 356,366 of its own B shares (KESKOB) held by the Company as treasury shares to members of management and other selected key persons who were included in the target group for the PSP 2019-2022 share-based commitment and incentive plan in the 2019 and 2020 performance periods, and to selected key persons in accordance with the terms and conditions of the RSP 2018-2020 plan. The transfer of the shares is based on a decision by Kesko's Board of Directors, announced in a stock exchange release on 3 February 2021, to grant own B shares held by

Notice to the Extraordinary General Meeting of Elekta AB (publ)

Shareholders of Elekta AB (publ), reg. no. 556170-4015, are hereby invited to attend the Extraordinary General Meeting to be held on Friday 16 April 2021. Due to the coronavirus pandemic, the Board of Directors has decided that the Meeting should be conducted without the physical presence of shareholders, representatives or third parties and that the shareholders before the meeting should be able to exercise their voting rights only by voting in advance, so-called advance voting. Information on the resolutions passed at the Meeting will be published on Friday 16 April 2021, as soon as

OP Mortgage Bank to issue the first-ever green covered bond in Finland

OP Mortgage Bank will issue a green covered bond worth 750 million euros in accordance with the Green Covered Bond Framework published in November.The green covered bond is the first of its kind issued in Finland. It amounts to 750 million euros and has a maturity of 10 years. The bond is targeted at responsible institutional investors, and proceeds raised with the bond are allocated to OP Financial Group’s home loans that are recognised as green ones according to the Framework. The sector to be financed is energy-efficient residential buildings (green buildings). The bond was priced on 18

Berlin-based start-up - The Stryze Group raises $100 million

Investments to fund development into the world's leading D2C brand house / Human-to-human model at the forefront at The Stryze The Stryze Group offers consumers high-quality direct-to-consumer (D2C) brands at fair prices across multiple platforms – anywhere, anytime. Now, Upper90, Alstin Capital and another German institutional investor are investing up to 100 million US dollars in the company. In addition to organic growth of own brands, this will also be used to finance acquisitions. "We are not financially driven, but interested in brands, their development and the people behind them,"

Lipum's final report for Horizon 2020 has been approved

Press release: Umeå, 18 March 2021. Lipum's final report for the EU's Horizon 2020 framework program has been approved and the company will receive 496,000 EUR as final payment from the program.Horizon 2020, the EU's framework program for research and development, has granted Lipum a total of EUR 2.2 million to develop SOL-116 for treatment of chronic inflammatory diseases. "The contribution from Horizon 2020 has been central and giving us the opportunity to develop the drug candidate SOL-116. This has a new mechanism of action and potential to be the first in a new drug class for

Hexagon and Mitsui expand and extend strategic alliance

Mitsui & Co., Ltd., headquartered in Tokyo and active world-wide in a wide range of sectors including clean energy & mobility, and Hexagon Composites ASA, a leader in the fast-developing clean fuel solutions category have extended their strategic alliance for an additional five years, effective from March 21, 2021. The agreement has also been expanded to include Hexagon Purus AS, which was recently spun-off and listed on Euronext Growth Oslo. “For the past 5 years, Mitsui has been a strong supporter of Hexagon Composites’ strategic development of new markets and new segments. With its

Aker Solutions ASA: Notice of Annual General Meeting

March 19, 2021 - The annual general meeting of Aker Solutions ASA will be held on Wednesday, April 14, 2021, at 09:00 CEST at Oksenøyveien 8, 1366 Fornebu, Norway.Due to the COVID-19 situation, we urge shareholders to vote electronically prior to the meeting or issue a proxy to the chairman, and not attend physically. Go to https://akersolutions.com/agm-2021 to cast your vote. The deadline for prior voting is April 12, 2021 at 09:00 CEST. Please find attached the following documents: · The notice of the general meeting including attendance and proxy forms · The board of

Clinical results for Episealer® accepted for presentation at the 19th ESSKA Congress

Episurf Medical (Nasdaq: EPIS B) today announces that an abstract with results from the European multicentre study with 24 months’ follow up of 75 Episealer® Knee patients has been accepted for presentation at the upcoming 19[th] ESSKA congress. The abstract, “Mini-metal implants - 2 year detailed cohort analysis of a patient specific implant“ is authored by Associate Professor Tim Spalding, University Hospitals Coventry and Warwickshire NHS Trust, UK.                 ESSKA (European Society for Sports Traumatology, Knee Surgery and Arthroscopy) is a European organisation focusing on

Nederman’s Annual Report 2020 published.

Nederman's annual report for 2020 is now published on our website. The printed version is currently being distributed to subscribers and new shareholders.  The annual report can be downloaded at www.nedermangroup.com. For further information, please contact:Sven Kristensson, CEO                                                                      Telephone: +46 42 18 87 00                                                            e-mail: sven.kristensson@nederman.com Matthew Cusick, CFOTelephone: +46 42 18 87 00e-mail: matthew.cusick@nederman.com This information is

Capital increase in TORM due to exercise of Restricted Share Units as part of the Company’s incentive program

TORM plc (“TORM”) increases its share capital by 58,271 A-shares (corresponding to a nominal value of USD 582.71) as a result of the exercise of a corresponding number of Restricted Share Units. The capital increase is carried out without any pre-emption rights for existing shareholders or others. The new shares have been subscribed for in cash at DKK 43.4 per A-share with a nominal value of USD 0.01 each. The new shares are ordinary shares without any special rights and are negotiable instruments. The new shares give right to dividends and other rights in relation to TORM as of the

Capacity and quality in focus when Högland invests in Valutec kilns

Höglands Såg & Hyvleri invests in two continuous kilns from Valutec for its sawmill at Anundsjö, Sweden. After the investments, the company’s drying capacity will reach 375,000 cubic meters (158,916 MBF) annually.“With the sawmill in full operation, we have experienced the lumber drying kilns as a limiting factor. This investments main benefits are the improved flow on our production line and the increased quality of the finished product,” says David Markusson, CEO of Höglands Såg & Hyvleri.Höglands Såg & Hyvleri is a family-owned company comprised of the sawmills, Höglandssågen and

Getinge launches interactive virtual hospital to showcase medtech solutions for customers

In addition to the physical Experience Centers where visitors can interact with Getinge’s products and solutions – a virtual hospital is now launching to simulate a state-of-the-art hospital environment also online. First out is Getinge’s solutions for the intensive care unit. Getinge Virtual Hospital will provide a comprehensive tour of hospital departments fully equipped with Getinge products and technologies – similar to the real-world Experience Centers in Germany, China, Japan and the USA. “In times when travel and in-person contact is very limited, the possibility to step

Changes in SEB’s Group Executive Committee

Sara Öhrvall has decided to leave her role in SEB's Group Executive Committee as Chief Transformation Officer, to take on a new role as Chief Operating Officer at Axel Johnson AB. “Sara has contributed to accelerating the journey of change we are on, not least by driving important initiatives in both digitisation and sustainability. I want to thank Sara for her important work. We are now well equipped to continue SEB's transformation and we wish her all the best in her new role at Axel Johnson,” says Johan Torgeby, President and CEO of SEB. “I am proud and grateful to have been part

Notice of Annual General Meeting in Bravida Holding AB (publ)

The shareholders of Bravida Holding AB (publ), reg. no. 556891-5390, with its registered office in Stockholm, Sweden, are summoned to the Annual General Meeting to be held on Monday 26 April 2021.Due to the extraordinary situation resulting from the covid-19 pandemic, the Annual General Meeting in Bravida will be carried out through advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the Annual General Meeting will be held without physical presence. Preconditions for

HANZA expands in Finland with new acquisition

HANZA Holding AB (publ) has today acquired Suomen Levyprofiili Oy (“SLP”), a successful Finnish manufacturer of sheet metal mechanics. The deal is an important step in HANZA's ongoing work to expand the Group's development clusters.SLP has just over 100 employees and operations in a modern production facility in Joensuu, close to HANZA's other factories in Finland. The acquisition complements HANZA's existing manufacturing technologies in Finland, and thus follows the company's business model of creating customer value by linking different factories and offering complete contract

Renoon och We aRe SpinDye inleder partnerskap

Idag lanserar We aRe SpinDye® och Renoon® ett officiellt samarbete där målet är att stärka medvetenheten hos slutkonsumenten kring hållbart mode i allmänhet och färgningens inverkan i synnerhet.Iris Skrami, grundare av Renoon, är mycket glad över att kunna presentera samarbetet. De senaste uppgifterna från Renoon belyser särskilt den fantastiska timingen för Renoon och We aRe SpinDyes® kommande samarbete. - Våra undersökningar visar att färgning är en av de viktigaste frågorna för de mest engagerade användarna av Renoon och hållbarhetsaspekter i samband med färgning fortsätter att öka,

Notice of Annual General Meeting in Atlas Copco AB

Nacka, Sweden, March 19, 2021: Atlas Copco AB will hold the Annual General Meeting Tuesday April 27, 2021.Due to the contagious Covid-19 and the authorities’ regulations/guidance on avoiding gatherings of people, the Board of Directors has decided that the annual general meeting should be held without physical presence by inviting the shareholders to exercise their voting rights only by mail voting. Information on the resolutions adopted by the general meeting will be published on April 27, 2021 as soon as the results of the mail vote has been finalized. For further information, see the

Executive Brief from CEO Michael Glantz

myFC’s Michael Glantz comments on recent market and company developments.“A number of major decisions regarding our financing, executive management and the board of directors have now been announced and implemented, which means I have the opportunity to return in an Executive Brief. I have been looking forward to that. Our newly elected Chairman of the Board Ulf Henning will shortly publish a Board Brief, so I leave it to him to comment on our financing and recent ownership changes. With the arrival of spring comes changes in my management team. In two weeks, I will welcome Mattias

Cantargia reports positive preclinical safety and efficacy results in the CAN10 project

Cantargia AB today announced new preclinical results strengthening the development plan of the antibody CAN10 for treatment of myocarditis and systemic sclerosis. In preclinical studies of myocarditis, CAN10 significantly counteracted disease development. CAN10 also potently decreased inflammatory disease in other models used to investigate the CAN10 mechanism of action. The first toxicology study, investigating single dose treatment of CAN10 up to 50 mg/kg, did not identify any safety signals.Cantargia develops antibody-based pharmaceuticals against interleukin-1 receptor accessory protein

Conveyance of Basware Corporation’s own shares

Basware Corporation, stock exchange release, March 19, 2021 at 09:00 a.m. EETThe Board of Directors of Basware Corporation has on March 18, 2021 decided on a directed share issue for the reward payment of Basware Corporation’s Performance Share Plan 2019-2020 and Matching Share Plan 2018-2020. In the share issue, 39,908 Basware Corporation shares have on March 18, 2021 been issued and conveyed without consideration to the key persons participating in the plans according to the terms and conditions of the incentive schemes. The shares will be transferred to the book-entry accounts of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top